nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP2A6—esophageal cancer	0.311	0.512	CbGaD
Nicotine—CYP19A1—esophageal cancer	0.296	0.488	CbGaD
Nicotine—SLC22A2—Cisplatin—esophageal cancer	0.0308	0.428	CbGbCtD
Nicotine—CYP2C9—Capecitabine—esophageal cancer	0.0168	0.233	CbGbCtD
Nicotine—CHAT—vagus nerve—esophageal cancer	0.0166	0.245	CbGeAlD
Nicotine—CYP2B6—Cisplatin—esophageal cancer	0.016	0.222	CbGbCtD
Nicotine—CYP2C9—Cisplatin—esophageal cancer	0.00845	0.117	CbGbCtD
Nicotine—Nasal ulcer—Capecitabine—esophageal cancer	0.00607	0.0675	CcSEcCtD
Nicotine—SLC22A4—larynx—esophageal cancer	0.00527	0.0776	CbGeAlD
Nicotine—Oral discomfort—Capecitabine—esophageal cancer	0.00497	0.0552	CcSEcCtD
Nicotine—Motor dysfunction—Methotrexate—esophageal cancer	0.00294	0.0326	CcSEcCtD
Nicotine—CYP2A13—lung—esophageal cancer	0.00292	0.0429	CbGeAlD
Nicotine—Oral herpes—Capecitabine—esophageal cancer	0.00243	0.027	CcSEcCtD
Nicotine—CHAT—digestive system—esophageal cancer	0.00188	0.0278	CbGeAlD
Nicotine—Pain in jaw—Capecitabine—esophageal cancer	0.00176	0.0195	CcSEcCtD
Nicotine—CHRNA5—lymph node—esophageal cancer	0.00171	0.0252	CbGeAlD
Nicotine—CHRNB2—bronchus—esophageal cancer	0.00169	0.0249	CbGeAlD
Nicotine—CHRNB2—smooth muscle tissue—esophageal cancer	0.00165	0.0243	CbGeAlD
Nicotine—CHRNA7—neck—esophageal cancer	0.0016	0.0235	CbGeAlD
Nicotine—CHRNB2—trachea—esophageal cancer	0.00152	0.0223	CbGeAlD
Nicotine—SLC22A4—neck—esophageal cancer	0.0014	0.0206	CbGeAlD
Nicotine—Hoarseness—Capecitabine—esophageal cancer	0.0013	0.0145	CcSEcCtD
Nicotine—Chest tightness—Capecitabine—esophageal cancer	0.00122	0.0136	CcSEcCtD
Nicotine—CHRFAM7A—trachea—esophageal cancer	0.00119	0.0175	CbGeAlD
Nicotine—CHRNB2—lung—esophageal cancer	0.00109	0.016	CbGeAlD
Nicotine—CHRNA3—lung—esophageal cancer	0.00106	0.0156	CbGeAlD
Nicotine—CHRNA4—bronchus—esophageal cancer	0.00105	0.0155	CbGeAlD
Nicotine—CHRNA10—lymph node—esophageal cancer	0.00104	0.0153	CbGeAlD
Nicotine—Sneezing—Capecitabine—esophageal cancer	0.00103	0.0115	CcSEcCtD
Nicotine—MAOA—neck—esophageal cancer	0.001	0.0148	CbGeAlD
Nicotine—Gastric ulcer—Capecitabine—esophageal cancer	0.000985	0.0109	CcSEcCtD
Nicotine—SLC22A2—digestive system—esophageal cancer	0.000975	0.0144	CbGeAlD
Nicotine—Rhinorrhoea—Cisplatin—esophageal cancer	0.000958	0.0106	CcSEcCtD
Nicotine—SLC22A4—bronchus—esophageal cancer	0.000936	0.0138	CbGeAlD
Nicotine—Ulcerative stomatitis—Methotrexate—esophageal cancer	0.000923	0.0103	CcSEcCtD
Nicotine—Tenderness—Cisplatin—esophageal cancer	0.00089	0.00989	CcSEcCtD
Nicotine—Aphasia—Capecitabine—esophageal cancer	0.000882	0.0098	CcSEcCtD
Nicotine—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.000848	0.00942	CcSEcCtD
Nicotine—SLC22A4—trachea—esophageal cancer	0.00084	0.0124	CbGeAlD
Nicotine—Laryngeal pain—Capecitabine—esophageal cancer	0.00084	0.00933	CcSEcCtD
Nicotine—SLC22A3—smooth muscle tissue—esophageal cancer	0.000833	0.0123	CbGeAlD
Nicotine—CHRNA7—digestive system—esophageal cancer	0.000826	0.0122	CbGeAlD
Nicotine—CHRNA4—digestive system—esophageal cancer	0.000815	0.012	CbGeAlD
Nicotine—Pain—Carboplatin—esophageal cancer	0.000808	0.00897	CcSEcCtD
Nicotine—Blister—Capecitabine—esophageal cancer	0.000794	0.00882	CcSEcCtD
Nicotine—MAOB—bronchus—esophageal cancer	0.000788	0.0116	CbGeAlD
Nicotine—Tongue disorder—Capecitabine—esophageal cancer	0.000787	0.00874	CcSEcCtD
Nicotine—Hiccups—Cisplatin—esophageal cancer	0.000776	0.00863	CcSEcCtD
Nicotine—Body temperature increased—Carboplatin—esophageal cancer	0.000747	0.00829	CcSEcCtD
Nicotine—CHRNB2—lymph node—esophageal cancer	0.000745	0.011	CbGeAlD
Nicotine—Fluid retention—Cisplatin—esophageal cancer	0.000737	0.00819	CcSEcCtD
Nicotine—Memory impairment—Capecitabine—esophageal cancer	0.000729	0.0081	CcSEcCtD
Nicotine—SLC22A4—digestive system—esophageal cancer	0.000723	0.0107	CbGeAlD
Nicotine—CHRNA3—lymph node—esophageal cancer	0.000722	0.0106	CbGeAlD
Nicotine—Tingling sensation—Capecitabine—esophageal cancer	0.000712	0.00791	CcSEcCtD
Nicotine—Rhinorrhoea—Capecitabine—esophageal cancer	0.000706	0.00785	CcSEcCtD
Nicotine—Dysphonia—Capecitabine—esophageal cancer	0.000696	0.00773	CcSEcCtD
Nicotine—CYP2A6—lung—esophageal cancer	0.000689	0.0102	CbGeAlD
Nicotine—CHRNA4—lung—esophageal cancer	0.00068	0.01	CbGeAlD
Nicotine—Extrasystoles—Capecitabine—esophageal cancer	0.00068	0.00756	CcSEcCtD
Nicotine—MAOA—bronchus—esophageal cancer	0.000672	0.00991	CbGeAlD
Nicotine—Eye irritation—Capecitabine—esophageal cancer	0.00067	0.00745	CcSEcCtD
Nicotine—Aphasia—Methotrexate—esophageal cancer	0.000657	0.0073	CcSEcCtD
Nicotine—Chest discomfort—Capecitabine—esophageal cancer	0.000647	0.00719	CcSEcCtD
Nicotine—Lacrimation increased—Capecitabine—esophageal cancer	0.000621	0.0069	CcSEcCtD
Nicotine—SLC22A5—bronchus—esophageal cancer	0.000619	0.00912	CbGeAlD
Nicotine—Nasal congestion—Cisplatin—esophageal cancer	0.000619	0.00687	CcSEcCtD
Nicotine—Burning sensation—Methotrexate—esophageal cancer	0.000613	0.00681	CcSEcCtD
Nicotine—MAOB—digestive system—esophageal cancer	0.000609	0.00897	CbGeAlD
Nicotine—SLC22A4—lung—esophageal cancer	0.000604	0.0089	CbGeAlD
Nicotine—MAOA—trachea—esophageal cancer	0.000604	0.0089	CbGeAlD
Nicotine—Amnesia—Cisplatin—esophageal cancer	0.0006	0.00667	CcSEcCtD
Nicotine—Coordination abnormal—Capecitabine—esophageal cancer	0.000583	0.00648	CcSEcCtD
Nicotine—Blood pressure increased—Capecitabine—esophageal cancer	0.000572	0.00636	CcSEcCtD
Nicotine—Hiccups—Capecitabine—esophageal cancer	0.000572	0.00636	CcSEcCtD
Nicotine—CYP1A1—epithelium—esophageal cancer	0.000562	0.00828	CbGeAlD
Nicotine—SLC22A5—trachea—esophageal cancer	0.000556	0.00819	CbGeAlD
Nicotine—Influenza like illness—Capecitabine—esophageal cancer	0.000556	0.00618	CcSEcCtD
Nicotine—CYP1A1—bronchus—esophageal cancer	0.000553	0.00815	CbGeAlD
Nicotine—SLC22A3—lung—esophageal cancer	0.00055	0.0081	CbGeAlD
Nicotine—Fluid retention—Capecitabine—esophageal cancer	0.000543	0.00604	CcSEcCtD
Nicotine—Gingivitis—Methotrexate—esophageal cancer	0.000543	0.00603	CcSEcCtD
Nicotine—Irritability—Cisplatin—esophageal cancer	0.000538	0.00598	CcSEcCtD
Nicotine—CYP2B6—bronchus—esophageal cancer	0.000538	0.00792	CbGeAlD
Nicotine—CYP2C19—digestive system—esophageal cancer	0.000531	0.00782	CbGeAlD
Nicotine—MAOA—digestive system—esophageal cancer	0.00052	0.00765	CbGeAlD
Nicotine—Mouth ulceration—Capecitabine—esophageal cancer	0.000517	0.00575	CcSEcCtD
Nicotine—MAOB—lung—esophageal cancer	0.000509	0.00749	CbGeAlD
Nicotine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000504	0.0056	CcSEcCtD
Nicotine—Abnormal vision—Capecitabine—esophageal cancer	0.000499	0.00555	CcSEcCtD
Nicotine—CYP1A1—trachea—esophageal cancer	0.000497	0.00732	CbGeAlD
Nicotine—Mental disability—Capecitabine—esophageal cancer	0.000497	0.00552	CcSEcCtD
Nicotine—Ear pain—Capecitabine—esophageal cancer	0.000487	0.00541	CcSEcCtD
Nicotine—Sleep disorder—Capecitabine—esophageal cancer	0.00048	0.00533	CcSEcCtD
Nicotine—SLC22A5—digestive system—esophageal cancer	0.000478	0.00705	CbGeAlD
Nicotine—Sweating increased—Cisplatin—esophageal cancer	0.000474	0.00527	CcSEcCtD
Nicotine—Abdominal discomfort—Cisplatin—esophageal cancer	0.000467	0.00519	CcSEcCtD
Nicotine—Hot flush—Capecitabine—esophageal cancer	0.000444	0.00493	CcSEcCtD
Nicotine—Amnesia—Capecitabine—esophageal cancer	0.000442	0.00491	CcSEcCtD
Nicotine—Increased appetite—Capecitabine—esophageal cancer	0.000442	0.00491	CcSEcCtD
Nicotine—Menopausal symptoms—Capecitabine—esophageal cancer	0.00044	0.00489	CcSEcCtD
Nicotine—Atrial fibrillation—Capecitabine—esophageal cancer	0.000438	0.00487	CcSEcCtD
Nicotine—Dermatitis bullous—Capecitabine—esophageal cancer	0.000435	0.00483	CcSEcCtD
Nicotine—MAOA—lung—esophageal cancer	0.000434	0.00639	CbGeAlD
Nicotine—Respiratory failure—Methotrexate—esophageal cancer	0.000434	0.00482	CcSEcCtD
Nicotine—CYP1A2—digestive system—esophageal cancer	0.000433	0.00639	CbGeAlD
Nicotine—CYP1A1—digestive system—esophageal cancer	0.000428	0.0063	CbGeAlD
Nicotine—Arthritis—Capecitabine—esophageal cancer	0.000427	0.00475	CcSEcCtD
Nicotine—Cardiac failure—Capecitabine—esophageal cancer	0.000426	0.00473	CcSEcCtD
Nicotine—Stomatitis—Cisplatin—esophageal cancer	0.000423	0.0047	CcSEcCtD
Nicotine—Cystitis noninfective—Methotrexate—esophageal cancer	0.000416	0.00462	CcSEcCtD
Nicotine—CYP2B6—digestive system—esophageal cancer	0.000415	0.00612	CbGeAlD
Nicotine—SLC22A4—lymph node—esophageal cancer	0.000413	0.00608	CbGeAlD
Nicotine—CYP2C9—digestive system—esophageal cancer	0.000411	0.00606	CbGeAlD
Nicotine—Cystitis—Methotrexate—esophageal cancer	0.000411	0.00457	CcSEcCtD
Nicotine—Migraine—Capecitabine—esophageal cancer	0.000409	0.00454	CcSEcCtD
Nicotine—SLC22A5—lung—esophageal cancer	0.0004	0.00589	CbGeAlD
Nicotine—Irritability—Capecitabine—esophageal cancer	0.000397	0.00441	CcSEcCtD
Nicotine—Mood swings—Capecitabine—esophageal cancer	0.000394	0.00437	CcSEcCtD
Nicotine—CYP2E1—digestive system—esophageal cancer	0.00039	0.00574	CbGeAlD
Nicotine—Bladder pain—Methotrexate—esophageal cancer	0.000385	0.00428	CcSEcCtD
Nicotine—Mouth ulceration—Methotrexate—esophageal cancer	0.000385	0.00428	CcSEcCtD
Nicotine—Abdominal pain upper—Capecitabine—esophageal cancer	0.000379	0.00422	CcSEcCtD
Nicotine—SLC22A3—lymph node—esophageal cancer	0.000376	0.00554	CbGeAlD
Nicotine—Visual impairment—Cisplatin—esophageal cancer	0.000376	0.00417	CcSEcCtD
Nicotine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000371	0.00413	CcSEcCtD
Nicotine—CYP19A1—lymph node—esophageal cancer	0.00037	0.00544	CbGeAlD
Nicotine—CYP1A2—lung—esophageal cancer	0.000362	0.00533	CbGeAlD
Nicotine—Flushing—Cisplatin—esophageal cancer	0.000362	0.00402	CcSEcCtD
Nicotine—Cardiac disorder—Cisplatin—esophageal cancer	0.000362	0.00402	CcSEcCtD
Nicotine—Dysphagia—Capecitabine—esophageal cancer	0.000359	0.00399	CcSEcCtD
Nicotine—Influenza—Capecitabine—esophageal cancer	0.000359	0.00399	CcSEcCtD
Nicotine—CYP1A1—lung—esophageal cancer	0.000357	0.00526	CbGeAlD
Nicotine—Bronchospasm—Capecitabine—esophageal cancer	0.000353	0.00392	CcSEcCtD
Nicotine—Immune system disorder—Cisplatin—esophageal cancer	0.000352	0.00391	CcSEcCtD
Nicotine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000351	0.0039	CcSEcCtD
Nicotine—Sweating increased—Capecitabine—esophageal cancer	0.00035	0.00389	CcSEcCtD
Nicotine—Arrhythmia—Cisplatin—esophageal cancer	0.000348	0.00387	CcSEcCtD
Nicotine—MAOB—lymph node—esophageal cancer	0.000348	0.00512	CbGeAlD
Nicotine—CYP2B6—lung—esophageal cancer	0.000347	0.00511	CbGeAlD
Nicotine—Bronchitis—Capecitabine—esophageal cancer	0.000345	0.00384	CcSEcCtD
Nicotine—Abdominal discomfort—Capecitabine—esophageal cancer	0.000344	0.00382	CcSEcCtD
Nicotine—Erythema—Cisplatin—esophageal cancer	0.000339	0.00377	CcSEcCtD
Nicotine—Flatulence—Cisplatin—esophageal cancer	0.000334	0.00372	CcSEcCtD
Nicotine—Weight increased—Capecitabine—esophageal cancer	0.000327	0.00363	CcSEcCtD
Nicotine—Muscle spasms—Cisplatin—esophageal cancer	0.000326	0.00363	CcSEcCtD
Nicotine—CYP2E1—lung—esophageal cancer	0.000326	0.0048	CbGeAlD
Nicotine—Tremor—Cisplatin—esophageal cancer	0.000318	0.00353	CcSEcCtD
Nicotine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000315	0.0035	CcSEcCtD
Nicotine—CYP3A4—digestive system—esophageal cancer	0.000314	0.00462	CbGeAlD
Nicotine—Stomatitis—Capecitabine—esophageal cancer	0.000312	0.00347	CcSEcCtD
Nicotine—CYP2D6—digestive system—esophageal cancer	0.000309	0.00455	CbGeAlD
Nicotine—Malaise—Cisplatin—esophageal cancer	0.000306	0.0034	CcSEcCtD
Nicotine—Epistaxis—Capecitabine—esophageal cancer	0.000302	0.00336	CcSEcCtD
Nicotine—MAOA—lymph node—esophageal cancer	0.000297	0.00437	CbGeAlD
Nicotine—Irritability—Methotrexate—esophageal cancer	0.000295	0.00328	CcSEcCtD
Nicotine—Convulsion—Cisplatin—esophageal cancer	0.000294	0.00327	CcSEcCtD
Nicotine—Mood swings—Methotrexate—esophageal cancer	0.000293	0.00326	CcSEcCtD
Nicotine—Myalgia—Cisplatin—esophageal cancer	0.000289	0.00321	CcSEcCtD
Nicotine—Rhinitis—Capecitabine—esophageal cancer	0.000288	0.0032	CcSEcCtD
Nicotine—Anxiety—Cisplatin—esophageal cancer	0.000288	0.0032	CcSEcCtD
Nicotine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000286	0.00318	CcSEcCtD
Nicotine—Discomfort—Cisplatin—esophageal cancer	0.000285	0.00317	CcSEcCtD
Nicotine—Pharyngitis—Capecitabine—esophageal cancer	0.000285	0.00317	CcSEcCtD
Nicotine—Oedema peripheral—Capecitabine—esophageal cancer	0.000283	0.00315	CcSEcCtD
Nicotine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000277	0.00308	CcSEcCtD
Nicotine—Oedema—Cisplatin—esophageal cancer	0.000277	0.00308	CcSEcCtD
Nicotine—Visual impairment—Capecitabine—esophageal cancer	0.000277	0.00308	CcSEcCtD
Nicotine—SLC22A5—lymph node—esophageal cancer	0.000273	0.00403	CbGeAlD
Nicotine—Nervous system disorder—Cisplatin—esophageal cancer	0.000272	0.00302	CcSEcCtD
Nicotine—Tachycardia—Cisplatin—esophageal cancer	0.00027	0.003	CcSEcCtD
Nicotine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000268	0.00298	CcSEcCtD
Nicotine—Flushing—Capecitabine—esophageal cancer	0.000267	0.00296	CcSEcCtD
Nicotine—Cardiac disorder—Capecitabine—esophageal cancer	0.000267	0.00296	CcSEcCtD
Nicotine—Immune system disorder—Capecitabine—esophageal cancer	0.00026	0.00288	CcSEcCtD
Nicotine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000259	0.00288	CcSEcCtD
Nicotine—Hypotension—Cisplatin—esophageal cancer	0.000259	0.00288	CcSEcCtD
Nicotine—Arrhythmia—Capecitabine—esophageal cancer	0.000257	0.00285	CcSEcCtD
Nicotine—Abdominal discomfort—Methotrexate—esophageal cancer	0.000256	0.00285	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000252	0.0028	CcSEcCtD
Nicotine—Mental disorder—Capecitabine—esophageal cancer	0.000252	0.0028	CcSEcCtD
Nicotine—Erythema—Capecitabine—esophageal cancer	0.00025	0.00278	CcSEcCtD
Nicotine—Paraesthesia—Cisplatin—esophageal cancer	0.000249	0.00276	CcSEcCtD
Nicotine—Dyspnoea—Cisplatin—esophageal cancer	0.000247	0.00274	CcSEcCtD
Nicotine—Flatulence—Capecitabine—esophageal cancer	0.000247	0.00274	CcSEcCtD
Nicotine—Dysgeusia—Capecitabine—esophageal cancer	0.000245	0.00272	CcSEcCtD
Nicotine—CYP1A1—lymph node—esophageal cancer	0.000244	0.0036	CbGeAlD
Nicotine—Back pain—Capecitabine—esophageal cancer	0.000242	0.00269	CcSEcCtD
Nicotine—Muscle spasms—Capecitabine—esophageal cancer	0.000241	0.00267	CcSEcCtD
Nicotine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000239	0.00266	CcSEcCtD
Nicotine—Pain—Cisplatin—esophageal cancer	0.000237	0.00263	CcSEcCtD
Nicotine—Tremor—Capecitabine—esophageal cancer	0.000234	0.0026	CcSEcCtD
Nicotine—Stomatitis—Methotrexate—esophageal cancer	0.000232	0.00258	CcSEcCtD
Nicotine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000232	0.00258	CcSEcCtD
Nicotine—Feeling abnormal—Cisplatin—esophageal cancer	0.000228	0.00254	CcSEcCtD
Nicotine—Malaise—Capecitabine—esophageal cancer	0.000226	0.00251	CcSEcCtD
Nicotine—Epistaxis—Methotrexate—esophageal cancer	0.000225	0.0025	CcSEcCtD
Nicotine—Vertigo—Capecitabine—esophageal cancer	0.000225	0.0025	CcSEcCtD
Nicotine—Syncope—Capecitabine—esophageal cancer	0.000224	0.00249	CcSEcCtD
Nicotine—Palpitations—Capecitabine—esophageal cancer	0.000221	0.00246	CcSEcCtD
Nicotine—Loss of consciousness—Capecitabine—esophageal cancer	0.00022	0.00244	CcSEcCtD
Nicotine—Body temperature increased—Cisplatin—esophageal cancer	0.000219	0.00243	CcSEcCtD
Nicotine—Cough—Capecitabine—esophageal cancer	0.000218	0.00243	CcSEcCtD
Nicotine—Hypertension—Capecitabine—esophageal cancer	0.000216	0.0024	CcSEcCtD
Nicotine—Arthralgia—Capecitabine—esophageal cancer	0.000213	0.00237	CcSEcCtD
Nicotine—Chest pain—Capecitabine—esophageal cancer	0.000213	0.00237	CcSEcCtD
Nicotine—Myalgia—Capecitabine—esophageal cancer	0.000213	0.00237	CcSEcCtD
Nicotine—Pharyngitis—Methotrexate—esophageal cancer	0.000212	0.00236	CcSEcCtD
Nicotine—Anxiety—Capecitabine—esophageal cancer	0.000212	0.00236	CcSEcCtD
Nicotine—Discomfort—Capecitabine—esophageal cancer	0.00021	0.00234	CcSEcCtD
Nicotine—Dry mouth—Capecitabine—esophageal cancer	0.000208	0.00231	CcSEcCtD
Nicotine—Visual impairment—Methotrexate—esophageal cancer	0.000206	0.00229	CcSEcCtD
Nicotine—Confusional state—Capecitabine—esophageal cancer	0.000206	0.00229	CcSEcCtD
Nicotine—Oedema—Capecitabine—esophageal cancer	0.000204	0.00227	CcSEcCtD
Nicotine—Hypersensitivity—Cisplatin—esophageal cancer	0.000204	0.00227	CcSEcCtD
Nicotine—Shock—Capecitabine—esophageal cancer	0.000201	0.00223	CcSEcCtD
Nicotine—Nervous system disorder—Capecitabine—esophageal cancer	0.0002	0.00222	CcSEcCtD
Nicotine—Tachycardia—Capecitabine—esophageal cancer	0.000199	0.00221	CcSEcCtD
Nicotine—Asthenia—Cisplatin—esophageal cancer	0.000199	0.00221	CcSEcCtD
Nicotine—Cardiac disorder—Methotrexate—esophageal cancer	0.000199	0.00221	CcSEcCtD
Nicotine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000197	0.00219	CcSEcCtD
Nicotine—Immune system disorder—Methotrexate—esophageal cancer	0.000193	0.00215	CcSEcCtD
Nicotine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000193	0.00214	CcSEcCtD
Nicotine—Hypotension—Capecitabine—esophageal cancer	0.000191	0.00212	CcSEcCtD
Nicotine—Diarrhoea—Cisplatin—esophageal cancer	0.00019	0.00211	CcSEcCtD
Nicotine—Mental disorder—Methotrexate—esophageal cancer	0.000187	0.00208	CcSEcCtD
Nicotine—Erythema—Methotrexate—esophageal cancer	0.000186	0.00207	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000186	0.00207	CcSEcCtD
Nicotine—Insomnia—Capecitabine—esophageal cancer	0.000185	0.00205	CcSEcCtD
Nicotine—Paraesthesia—Capecitabine—esophageal cancer	0.000183	0.00204	CcSEcCtD
Nicotine—Dysgeusia—Methotrexate—esophageal cancer	0.000182	0.00203	CcSEcCtD
Nicotine—Dyspnoea—Capecitabine—esophageal cancer	0.000182	0.00202	CcSEcCtD
Nicotine—Back pain—Methotrexate—esophageal cancer	0.00018	0.002	CcSEcCtD
Nicotine—Dyspepsia—Capecitabine—esophageal cancer	0.00018	0.002	CcSEcCtD
Nicotine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000176	0.00196	CcSEcCtD
Nicotine—Vomiting—Cisplatin—esophageal cancer	0.000176	0.00196	CcSEcCtD
Nicotine—Fatigue—Capecitabine—esophageal cancer	0.000176	0.00196	CcSEcCtD
Nicotine—Rash—Cisplatin—esophageal cancer	0.000175	0.00194	CcSEcCtD
Nicotine—Constipation—Capecitabine—esophageal cancer	0.000175	0.00194	CcSEcCtD
Nicotine—Pain—Capecitabine—esophageal cancer	0.000175	0.00194	CcSEcCtD
Nicotine—Dermatitis—Cisplatin—esophageal cancer	0.000174	0.00194	CcSEcCtD
Nicotine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000173	0.00192	CcSEcCtD
Nicotine—Feeling abnormal—Capecitabine—esophageal cancer	0.000168	0.00187	CcSEcCtD
Nicotine—Malaise—Methotrexate—esophageal cancer	0.000168	0.00187	CcSEcCtD
Nicotine—Vertigo—Methotrexate—esophageal cancer	0.000167	0.00186	CcSEcCtD
Nicotine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000167	0.00186	CcSEcCtD
Nicotine—Nausea—Cisplatin—esophageal cancer	0.000165	0.00183	CcSEcCtD
Nicotine—Cough—Methotrexate—esophageal cancer	0.000163	0.00181	CcSEcCtD
Nicotine—Urticaria—Capecitabine—esophageal cancer	0.000162	0.0018	CcSEcCtD
Nicotine—Body temperature increased—Capecitabine—esophageal cancer	0.000161	0.00179	CcSEcCtD
Nicotine—Abdominal pain—Capecitabine—esophageal cancer	0.000161	0.00179	CcSEcCtD
Nicotine—Convulsion—Methotrexate—esophageal cancer	0.000161	0.00179	CcSEcCtD
Nicotine—Arthralgia—Methotrexate—esophageal cancer	0.000159	0.00176	CcSEcCtD
Nicotine—Chest pain—Methotrexate—esophageal cancer	0.000159	0.00176	CcSEcCtD
Nicotine—Myalgia—Methotrexate—esophageal cancer	0.000159	0.00176	CcSEcCtD
Nicotine—Discomfort—Methotrexate—esophageal cancer	0.000157	0.00174	CcSEcCtD
Nicotine—Confusional state—Methotrexate—esophageal cancer	0.000153	0.0017	CcSEcCtD
Nicotine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000152	0.00169	CcSEcCtD
Nicotine—Hypersensitivity—Capecitabine—esophageal cancer	0.00015	0.00167	CcSEcCtD
Nicotine—Nervous system disorder—Methotrexate—esophageal cancer	0.000149	0.00166	CcSEcCtD
Nicotine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000147	0.00163	CcSEcCtD
Nicotine—Asthenia—Capecitabine—esophageal cancer	0.000147	0.00163	CcSEcCtD
Nicotine—Pruritus—Capecitabine—esophageal cancer	0.000144	0.00161	CcSEcCtD
Nicotine—Hypotension—Methotrexate—esophageal cancer	0.000142	0.00158	CcSEcCtD
Nicotine—Diarrhoea—Capecitabine—esophageal cancer	0.00014	0.00155	CcSEcCtD
Nicotine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000138	0.00154	CcSEcCtD
Nicotine—Insomnia—Methotrexate—esophageal cancer	0.000137	0.00153	CcSEcCtD
Nicotine—Paraesthesia—Methotrexate—esophageal cancer	0.000136	0.00152	CcSEcCtD
Nicotine—Dyspnoea—Methotrexate—esophageal cancer	0.000136	0.00151	CcSEcCtD
Nicotine—Somnolence—Methotrexate—esophageal cancer	0.000135	0.0015	CcSEcCtD
Nicotine—Dizziness—Capecitabine—esophageal cancer	0.000135	0.0015	CcSEcCtD
Nicotine—Dyspepsia—Methotrexate—esophageal cancer	0.000134	0.00149	CcSEcCtD
Nicotine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000131	0.00146	CcSEcCtD
Nicotine—Fatigue—Methotrexate—esophageal cancer	0.000131	0.00146	CcSEcCtD
Nicotine—Pain—Methotrexate—esophageal cancer	0.00013	0.00144	CcSEcCtD
Nicotine—Vomiting—Capecitabine—esophageal cancer	0.00013	0.00144	CcSEcCtD
Nicotine—Rash—Capecitabine—esophageal cancer	0.000129	0.00143	CcSEcCtD
Nicotine—Dermatitis—Capecitabine—esophageal cancer	0.000129	0.00143	CcSEcCtD
Nicotine—Headache—Capecitabine—esophageal cancer	0.000128	0.00142	CcSEcCtD
Nicotine—Feeling abnormal—Methotrexate—esophageal cancer	0.000125	0.00139	CcSEcCtD
Nicotine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000124	0.00138	CcSEcCtD
Nicotine—Nausea—Capecitabine—esophageal cancer	0.000121	0.00135	CcSEcCtD
Nicotine—Urticaria—Methotrexate—esophageal cancer	0.000121	0.00134	CcSEcCtD
Nicotine—Body temperature increased—Methotrexate—esophageal cancer	0.00012	0.00134	CcSEcCtD
Nicotine—Abdominal pain—Methotrexate—esophageal cancer	0.00012	0.00134	CcSEcCtD
Nicotine—Hypersensitivity—Methotrexate—esophageal cancer	0.000112	0.00124	CcSEcCtD
Nicotine—Asthenia—Methotrexate—esophageal cancer	0.000109	0.00121	CcSEcCtD
Nicotine—Pruritus—Methotrexate—esophageal cancer	0.000108	0.00119	CcSEcCtD
Nicotine—Diarrhoea—Methotrexate—esophageal cancer	0.000104	0.00116	CcSEcCtD
Nicotine—Dizziness—Methotrexate—esophageal cancer	0.000101	0.00112	CcSEcCtD
Nicotine—Vomiting—Methotrexate—esophageal cancer	9.66e-05	0.00107	CcSEcCtD
Nicotine—Rash—Methotrexate—esophageal cancer	9.58e-05	0.00106	CcSEcCtD
Nicotine—Dermatitis—Methotrexate—esophageal cancer	9.58e-05	0.00106	CcSEcCtD
Nicotine—Headache—Methotrexate—esophageal cancer	9.52e-05	0.00106	CcSEcCtD
Nicotine—Nausea—Methotrexate—esophageal cancer	9.03e-05	0.001	CcSEcCtD
Nicotine—CYP2E1—Metabolism—GSTT1—esophageal cancer	9.47e-06	5.82e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TPI1—esophageal cancer	9.42e-06	5.79e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTO1—esophageal cancer	9.42e-06	5.79e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ALDH2—esophageal cancer	9.38e-06	5.77e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	9.36e-06	5.75e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	9.32e-06	5.73e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	9.24e-06	5.68e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GNG7—esophageal cancer	9.18e-06	5.64e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—CREBBP—esophageal cancer	9.12e-06	5.61e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP19A1—esophageal cancer	9.11e-06	5.6e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALOX15—esophageal cancer	9.08e-06	5.58e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS1—esophageal cancer	9.06e-06	5.57e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ENO1—esophageal cancer	9.06e-06	5.57e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALDOB—esophageal cancer	9.03e-06	5.55e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALOX15—esophageal cancer	9e-06	5.53e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	8.97e-06	5.52e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GSTT1—esophageal cancer	8.93e-06	5.49e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PSME1—esophageal cancer	8.93e-06	5.49e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PSME2—esophageal cancer	8.93e-06	5.49e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—HMOX1—esophageal cancer	8.92e-06	5.48e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ENO1—esophageal cancer	8.87e-06	5.45e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS1—esophageal cancer	8.87e-06	5.45e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PTGS2—esophageal cancer	8.83e-06	5.43e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP2A6—esophageal cancer	8.82e-06	5.42e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.79e-06	5.4e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CA1—esophageal cancer	8.79e-06	5.4e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.79e-06	5.4e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PSME1—esophageal cancer	8.74e-06	5.37e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PSME2—esophageal cancer	8.74e-06	5.37e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GAPDH—esophageal cancer	8.69e-06	5.34e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTO1—esophageal cancer	8.66e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TPI1—esophageal cancer	8.66e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CRABP1—esophageal cancer	8.62e-06	5.3e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ALDH2—esophageal cancer	8.6e-06	5.29e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTO1—esophageal cancer	8.59e-06	5.28e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TPI1—esophageal cancer	8.59e-06	5.28e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—ABCB1—esophageal cancer	8.56e-06	5.26e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ADH1B—esophageal cancer	8.49e-06	5.22e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS1—esophageal cancer	8.36e-06	5.14e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ENO1—esophageal cancer	8.36e-06	5.14e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—HMOX1—esophageal cancer	8.31e-06	5.11e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALDOB—esophageal cancer	8.31e-06	5.11e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PSME2—esophageal cancer	8.24e-06	5.07e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PSME1—esophageal cancer	8.24e-06	5.07e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALDOB—esophageal cancer	8.24e-06	5.06e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GNG7—esophageal cancer	8.2e-06	5.04e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—HMOX1—esophageal cancer	8.19e-06	5.03e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GSTT1—esophageal cancer	8.18e-06	5.03e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—NOS3—esophageal cancer	8.17e-06	5.02e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TYMP—esophageal cancer	8.12e-06	4.99e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.09e-06	4.97e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.06e-06	4.95e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CA2—esophageal cancer	8.04e-06	4.94e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GAPDH—esophageal cancer	8e-06	4.91e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—ABCB1—esophageal cancer	7.98e-06	4.91e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GAPDH—esophageal cancer	7.93e-06	4.87e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CRABP1—esophageal cancer	7.92e-06	4.87e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP26A1—esophageal cancer	7.9e-06	4.85e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—ABCB1—esophageal cancer	7.86e-06	4.83e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CRABP1—esophageal cancer	7.86e-06	4.83e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	7.7e-06	4.73e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALOX15—esophageal cancer	7.69e-06	4.73e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ALDH2—esophageal cancer	7.68e-06	4.72e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ENO1—esophageal cancer	7.67e-06	4.71e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS1—esophageal cancer	7.67e-06	4.71e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PSME1—esophageal cancer	7.56e-06	4.64e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PSME2—esophageal cancer	7.56e-06	4.64e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	7.54e-06	4.64e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GNG7—esophageal cancer	7.54e-06	4.63e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ADH7—esophageal cancer	7.47e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.47e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GNG7—esophageal cancer	7.47e-06	4.59e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PTGS2—esophageal cancer	7.47e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.47e-06	4.59e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—EP300—esophageal cancer	7.34e-06	4.51e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTO1—esophageal cancer	7.34e-06	4.51e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TPI1—esophageal cancer	7.34e-06	4.51e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GSTT1—esophageal cancer	7.3e-06	4.49e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	7.24e-06	4.45e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	7.22e-06	4.44e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.2e-06	4.42e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.19e-06	4.42e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP1B1—esophageal cancer	7.11e-06	4.37e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	7.09e-06	4.36e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.06e-06	4.34e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALDOB—esophageal cancer	7.04e-06	4.33e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ALDH2—esophageal cancer	7e-06	4.3e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ENO1—esophageal cancer	6.84e-06	4.21e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS1—esophageal cancer	6.84e-06	4.21e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GAPDH—esophageal cancer	6.77e-06	4.16e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CREBBP—esophageal cancer	6.77e-06	4.16e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PSME2—esophageal cancer	6.74e-06	4.15e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PSME1—esophageal cancer	6.74e-06	4.15e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GSTT1—esophageal cancer	6.72e-06	4.13e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CRABP1—esophageal cancer	6.71e-06	4.13e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP19A1—esophageal cancer	6.69e-06	4.11e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GSTT1—esophageal cancer	6.66e-06	4.09e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	6.64e-06	4.08e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—HMOX1—esophageal cancer	6.61e-06	4.06e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CREBBP—esophageal cancer	6.6e-06	4.06e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.6e-06	4.06e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	6.58e-06	4.05e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.56e-06	4.03e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.55e-06	4.03e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.52e-06	4.01e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—HMOX1—esophageal cancer	6.47e-06	3.98e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GNG7—esophageal cancer	6.39e-06	3.92e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—ABCB1—esophageal cancer	6.34e-06	3.9e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ENO1—esophageal cancer	6.3e-06	3.87e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS1—esophageal cancer	6.3e-06	3.87e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TYMP—esophageal cancer	6.26e-06	3.85e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ENO1—esophageal cancer	6.24e-06	3.84e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.24e-06	3.84e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—EP300—esophageal cancer	6.21e-06	3.82e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—ABCB1—esophageal cancer	6.21e-06	3.82e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PSME1—esophageal cancer	6.2e-06	3.81e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PSME2—esophageal cancer	6.2e-06	3.81e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PSME1—esophageal cancer	6.15e-06	3.78e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PSME2—esophageal cancer	6.15e-06	3.78e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.13e-06	3.77e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—HMOX1—esophageal cancer	6.1e-06	3.75e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.09e-06	3.75e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—NOS3—esophageal cancer	6.06e-06	3.72e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.99e-06	3.68e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ALDH2—esophageal cancer	5.98e-06	3.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALOX15—esophageal cancer	5.94e-06	3.65e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—NOS3—esophageal cancer	5.91e-06	3.63e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.89e-06	3.62e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—ABCB1—esophageal cancer	5.86e-06	3.6e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	5.82e-06	3.58e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CREBBP—esophageal cancer	5.72e-06	3.52e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GSTT1—esophageal cancer	5.69e-06	3.5e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TPI1—esophageal cancer	5.66e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.66e-06	3.48e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP2A6—esophageal cancer	5.63e-06	3.46e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.6e-06	3.44e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.59e-06	3.44e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PTGS2—esophageal cancer	5.54e-06	3.41e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.49e-06	3.37e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	5.47e-06	3.36e-05	CbGpPWpGaD
Nicotine—MAOB—Metabolism—PIK3CA—esophageal cancer	5.43e-06	3.34e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.43e-06	3.34e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PTGS2—esophageal cancer	5.4e-06	3.32e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.37e-06	3.3e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.37e-06	3.3e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.35e-06	3.29e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CREBBP—esophageal cancer	5.33e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ENO1—esophageal cancer	5.33e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS1—esophageal cancer	5.33e-06	3.28e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.31e-06	3.26e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PSME1—esophageal cancer	5.26e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PSME2—esophageal cancer	5.26e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CREBBP—esophageal cancer	5.25e-06	3.23e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.23e-06	3.21e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.18e-06	3.18e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NOS3—esophageal cancer	5.12e-06	3.15e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.03e-06	3.09e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HMOX1—esophageal cancer	4.99e-06	3.07e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	4.99e-06	3.07e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GNG7—esophageal cancer	4.93e-06	3.03e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.9e-06	3.01e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—ABCB1—esophageal cancer	4.79e-06	2.95e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NOS3—esophageal cancer	4.78e-06	2.94e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NOS3—esophageal cancer	4.7e-06	2.89e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PTGS2—esophageal cancer	4.69e-06	2.88e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.62e-06	2.84e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—EP300—esophageal cancer	4.61e-06	2.83e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PIK3CA—esophageal cancer	4.6e-06	2.83e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.59e-06	2.82e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.59e-06	2.82e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HMOX1—esophageal cancer	4.55e-06	2.8e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP1B1—esophageal cancer	4.53e-06	2.79e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—EP300—esophageal cancer	4.5e-06	2.76e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.47e-06	2.75e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.43e-06	2.72e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.41e-06	2.71e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.39e-06	2.7e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.37e-06	2.69e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PTGS2—esophageal cancer	4.37e-06	2.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.34e-06	2.67e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PTGS2—esophageal cancer	4.3e-06	2.64e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP19A1—esophageal cancer	4.26e-06	2.62e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CREBBP—esophageal cancer	4.24e-06	2.61e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CREBBP—esophageal cancer	4.15e-06	2.55e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ENO1—esophageal cancer	4.12e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.12e-06	2.53e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.06e-06	2.5e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PSME2—esophageal cancer	4.06e-06	2.49e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PSME1—esophageal cancer	4.06e-06	2.49e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CREBBP—esophageal cancer	3.91e-06	2.41e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—EP300—esophageal cancer	3.9e-06	2.4e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HMOX1—esophageal cancer	3.89e-06	2.39e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.82e-06	2.35e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NOS3—esophageal cancer	3.8e-06	2.33e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—ABCB1—esophageal cancer	3.73e-06	2.3e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NOS3—esophageal cancer	3.72e-06	2.28e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—EP300—esophageal cancer	3.63e-06	2.23e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.62e-06	2.23e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.59e-06	2.21e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—EP300—esophageal cancer	3.58e-06	2.2e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NOS3—esophageal cancer	3.5e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.5e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PTGS2—esophageal cancer	3.47e-06	2.13e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PIK3CA—esophageal cancer	3.41e-06	2.1e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PTGS2—esophageal cancer	3.4e-06	2.09e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PIK3CA—esophageal cancer	3.33e-06	2.04e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.3e-06	2.03e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.29e-06	2.02e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NOS3—esophageal cancer	3.21e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PTGS2—esophageal cancer	3.21e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.2e-06	1.97e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HMOX1—esophageal cancer	3e-06	1.85e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CREBBP—esophageal cancer	2.95e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.94e-06	1.81e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.92e-06	1.8e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—EP300—esophageal cancer	2.89e-06	1.77e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	2.88e-06	1.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.88e-06	1.77e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NOS3—esophageal cancer	2.87e-06	1.76e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—EP300—esophageal cancer	2.83e-06	1.74e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.82e-06	1.74e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PIK3CA—esophageal cancer	2.69e-06	1.65e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—EP300—esophageal cancer	2.67e-06	1.64e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	2.65e-06	1.63e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NOS3—esophageal cancer	2.64e-06	1.62e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.62e-06	1.61e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NOS3—esophageal cancer	2.61e-06	1.61e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CREBBP—esophageal cancer	2.5e-06	1.53e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—EP300—esophageal cancer	2.44e-06	1.5e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.41e-06	1.48e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.39e-06	1.47e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NOS3—esophageal cancer	2.23e-06	1.37e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—EP300—esophageal cancer	2.18e-06	1.34e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.14e-06	1.31e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PTGS2—esophageal cancer	2.04e-06	1.26e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—EP300—esophageal cancer	2.01e-06	1.23e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—EP300—esophageal cancer	1.99e-06	1.22e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PIK3CA—esophageal cancer	1.97e-06	1.21e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.93e-06	1.18e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.81e-06	1.11e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.72e-06	1.06e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—EP300—esophageal cancer	1.7e-06	1.04e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.61e-06	9.92e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.58e-06	9.69e-06	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.48e-06	9.12e-06	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.47e-06	9.04e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—EP300—esophageal cancer	1.31e-06	8.06e-06	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PIK3CA—esophageal cancer	1.26e-06	7.73e-06	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.7e-07	5.96e-06	CbGpPWpGaD
